Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 0.120 | None | 0.667 | 1 | 1 | 2004 | 2018 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
disease | 0.130 | None | 0.750 | 1 | 1 | 2000 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.200 | None | 0.833 | 3 | 5 | 1996 | 2018 | ||||||||
|
collagen type IV alpha 2 chain | 0.563 | 0.654 | 3.6E-15 |
|
disease | 0.140 | None | 0.857 | 2 | 2 | 2011 | 2018 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.140 | None | 0.875 | 3 | 3 | 2010 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
disease | 0.150 | None | 0.875 | 2 | 3 | 2011 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.500 | None | 0.900 | 3 | 2 | 2010 | 2019 | |||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.450 | None | 0.900 | 2 | 3 | 2009 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.200 | None | 0.900 | 1 | 1 | 1991 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.500 | None | 0.918 | 4 | 1 | 1996 | 2020 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.200 | None | 0.918 | 1 | 4 | 1993 | 2020 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.200 | None | 0.933 | 1 | 1 | 1995 | 2019 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
disease | 0.500 | None | 0.938 | 2 | 2 | 2001 | 2019 | ||||||||
|
angiopoietin like 4 | 0.498 | 0.731 | 2.3E-11 |
|
disease | 0.500 | None | 0.941 | 2 | 1 | 2008 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.200 | None | 0.941 | 1 | 1 | 1999 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.958 | 7 | 8 | 1988 | 2019 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 0.978 | 9 | 8 | 2007 | 2019 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.200 | None | 0.980 | 3 | 1 | 1983 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 0.982 | 1 | 1 | 2000 | 2019 | ||||||||
|
proprotein convertase subtilisin/kexin type 9 | 0.482 | 0.808 | 2.7E-17 |
|
disease | 0.500 | None | 0.987 | 3 | 1 | 2006 | 2020 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.500 | None | 0.989 | 2 | 2 | 1986 | 2020 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.500 | None | 1.000 | 5 | 1 | 2011 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 2 | 0.656 | 0.577 | 1.00 |
|
disease | 0.140 | None | 1.000 | 4 | 3 | 2008 | 2018 | ||||||||
|
switching B cell complex subunit SWAP70 | 0.736 | 0.385 | 5.0E-02 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2018 |